2014
DOI: 10.4172/2329-6895.1000190
|View full text |Cite
|
Sign up to set email alerts
|

Stem Cells may Beat Riluzole in Treatment of Amyotrophic Lateral Sclerosis

Abstract: Amyotrophic lateral sclerosis, commonly known as Lou Gehrig's disease, or simply ALS, is a neurodegenerative disease that slowly kills its victims within a few years after diagnosis. This is a complex disease in which every motor neuron in the body is killed over a relatively short time period-within 3 years or so, thus killing the victim. This disease can be classified into three main categories based on the neurological levels affected-bulbar onset, cervical onset, and lumbar onset (Mitchell and Borasio). Bu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2017
2017

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 18 publications
0
1
0
Order By: Relevance
“…Despite its documented efficacy, riluzole utilization is not without controversy e.g., there is only a small increase in survival duration and it may not have a real value regarding the disability itself and/or the quality of life of the patients VOLUME 1, NUMBER 2, 2017 (Turner, 2003). Hence, several recent studies have shifted their focus away from drug therapy and on to the use of stem cells (Thomas, 2014).…”
Section: Introductionmentioning
confidence: 99%
“…Despite its documented efficacy, riluzole utilization is not without controversy e.g., there is only a small increase in survival duration and it may not have a real value regarding the disability itself and/or the quality of life of the patients VOLUME 1, NUMBER 2, 2017 (Turner, 2003). Hence, several recent studies have shifted their focus away from drug therapy and on to the use of stem cells (Thomas, 2014).…”
Section: Introductionmentioning
confidence: 99%